Physician profile
Christopher L Acone
NPI 1659576551
$834.11
in general payments reported to CMS, 2019-2025
11 companies · $35.57 in 2025
The $35.57 reported for 2025 was less than what a typical Periodontics provider received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $83.79 · 2021: $158 · 2022: $175 · 2023: $238 · 2024: $33.66 · 2025: $35.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $274 · Education: $33.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $273.69 |
| Education | $33.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nobel Biocare USA | $160.47 | 2019-2023 | Nobelactive |
| Geistlich Pharma, North America, INC. | $144.57 | 2021-2022 | |
| Ace Surgical Supply Co., INC. | $126.39 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $118.12 | 2019-2021 | |
| Straumann USA LLC | $102.86 | 2023-2025 | |
| Biolase, INC. | $100.82 | 2023 | Waterlase Iplus |
| Biohorizons Implant Systems INC. | $19.14 | 2023 | Biohorizons |
| Dentsply Sirona INC | $18.53 | 2019 | |
| Kulzer, LLC | $15.76 | 2020 | |
| Salvin Dental Specialties, INC. | $14.32 | 2019 | |
| Gc America INC. | $13.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Acone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.